Literature DB >> 2438040

Continuous sc infusion of narcotics using a portable disposable device in patients with advanced cancer.

E Bruera, C Brenneis, M Michaud, S Chadwick, R N MacDonald.   

Abstract

Fifty-six patients with chronic pain due to advanced cancer were treated with an sc infusion of morphone (34 patients) or hydromorphone (22 patients) using a portable disposable infusor. The infusion was maintained for 26 +/- 14 days. Twenty-five patients (45%) were discharged to the home for a mean period of 18 days (range, 2-138). The mean daily increase in dose was 2.6% +/- 1.4% of the initial dose. The sc site needed to be changed every 8 days (range, 2-31). Local toxicity consisted of infection in two patients (3%), chemical irritation in three (5%), and bleeding in one (2%). After 48 hours of treatment, 54 of 56 patients (96%) preferred the sc infusion to their previous parenteral treatment. We conclude that this is a safe and simple method for the administration of narcotics to inpatients and outpatients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438040

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  5 in total

1.  Comparison of continuous epidural infusion and intermittent bolus epidural injection of local anesthetics for postoperative pain relief.

Authors:  H Mitsuhata; S Matsumoto; M Yabe; K Ohtaka; S Shigeomi; J Matsumoto; T Matsuoka
Journal:  J Anesth       Date:  1991-10       Impact factor: 2.078

Review 2.  Pharmacological management of cancer pain.

Authors:  S A Schug; R Dunlop; D Zech
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

3.  Subcutaneous narcotic infusions for cancer pain: treatment outcome and guidelines for use.

Authors:  D E Moulin; N G Johnson; N Murray-Parsons; M F Geoghegan; V A Goodwin; M A Chester
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

4.  [Continuous subcutaneous buprenorphine application in the treatment of cancer pain.].

Authors:  I Gralow; W F von Hornstein; E Schleyer; W Hiddemann
Journal:  Schmerz       Date:  1995-05       Impact factor: 1.107

5.  Management of pain in the cancer patient.

Authors:  Shalini Dalal; Eduardo Bruera
Journal:  Front Pain Res (Lausanne)       Date:  2022-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.